Hepatic complications of breast cancer (Q37501576)

20 August 2017

1 reference

title

Hepatic complications of breast cancer (English)

1 reference

20 August 2017

1 reference

Jennifer R Diamond

1

1 reference

20 August 2017

Christina A Finlayson

series ordinal

2

1 reference

20 August 2017

Virginia F Borges

series ordinal

3

1 reference

20 August 2017

publication date

1 June 2009

1 reference

Lancet Oncology Commission

20 August 2017

published in

1 reference

20 August 2017

volume

10

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

615-621

1 reference

20 August 2017

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Clinical course of breast cancer patients with liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Patterns of clinical metastasis in breast cancer: an analysis of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

A pictorial review of the varied appearance of atypical liver metastasis from carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Metastatic carcinomatosis of the liver mimicking cirrhosis: Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Metastatic Breast Carcinoma Mimicking Macronodular Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Diffuse desmoplastic breast carcinoma metastases to the liver simulating cirrhosis at MR imaging: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Fulminant hepatic failure caused by diffuse intrasinusoidal metastatic liver disease: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Acute liver failure complicating ductal breast carcinoma: two cases and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

The distribution of secondary growths in cancer of the breast. 1889

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Organotropism of breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Functional pathways shared by liver and lung metastases: a mitochondrial chaperone machine is up-regulated in soft-tissue breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Role of fulvestrant in sequential hormonal therapy for advanced, hormone receptor-positive breast cancer in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Hepatectomy for metastatic noncolorectal gastrointestinal, breast and testicular tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Hepatic resection in breast cancer metastases: should it be considered standard treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Liver resection for metastases from breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Local ablation for unresectable liver tumors: is thermal best?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

The use of radiofrequency in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Chemoembolization of liver metastasis from breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Metastatic breast cancer in a 54-year-old woman: integrative treatment with yttrium-90 radioembolization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

A rationale for the targeted treatment of oligometastases with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Malignant ascites: systematic review and guideline for treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

Drug-induced liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

A problem-oriented approach to liver disease in oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970029-4

7 January 2021

10.1016/S1470-2045(09)70029-4

Identifiers

DOI

1 reference

20 August 2017

1 reference